- 全部删除
您的购物车当前为空
PARP7-IN-16是一种高效、选择性且具有口服生物活性的PARP-1/2/7抑制剂,其IC50分别为0.94 nM , 0.87 nM 和0.21 nM 。PARP7-IN-16适合用于乳腺癌与前列腺癌的研究。

PARP7-IN-16是一种高效、选择性且具有口服生物活性的PARP-1/2/7抑制剂,其IC50分别为0.94 nM , 0.87 nM 和0.21 nM 。PARP7-IN-16适合用于乳腺癌与前列腺癌的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 8-10周 | |
| 50 mg | 待询 | 8-10周 |
PARP7-IN-16 相关产品
| 产品描述 | PARP7-IN-16 (compound 36) is a potent, selective, and orally active PARP-1/2/7 inhibitor, exhibiting IC50 values of 0.94, 0.87, and 0.21 nM , respectively. It has potential applications in breast and prostate cancer research [1]. |
| 靶点活性 | PARP7:0.21 nM, PARP2:0.87 nM, PARP1:0.94 nM |
| 分子量 | 488.49 |
| 分子式 | C25H26FN4NaO4 |
| CAS No. | 2435657-10-4 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容